Search details
1.
Investigating the concordance in molecular subtypes of primary colorectal tumors and their matched synchronous liver metastasis.
Int J Cancer
; 147(8): 2303-2315, 2020 10 15.
Article
in English
| MEDLINE | ID: mdl-32270478
2.
A breast cancer gene signature for indolent disease.
Breast Cancer Res Treat
; 164(2): 461-466, 2017 Jul.
Article
in English
| MEDLINE | ID: mdl-28451965
3.
Equivalence of MammaPrint array types in clinical trials and diagnostics.
Breast Cancer Res Treat
; 156(2): 279-87, 2016 Apr.
Article
in English
| MEDLINE | ID: mdl-27002507
4.
Colorectal cancer intrinsic subtypes predict chemotherapy benefit, deficient mismatch repair and epithelial-to-mesenchymal transition.
Int J Cancer
; 134(3): 552-62, 2014 Feb 01.
Article
in English
| MEDLINE | ID: mdl-23852808
5.
A combined oncogenic pathway signature of BRAF, KRAS and PI3KCA mutation improves colorectal cancer classification and cetuximab treatment prediction.
Gut
; 62(4): 540-9, 2013 Apr.
Article
in English
| MEDLINE | ID: mdl-22798500
6.
Independent validation of a prognostic genomic signature (ColoPrint) for patients with stage II colon cancer.
Ann Surg
; 257(6): 1053-8, 2013 Jun.
Article
in English
| MEDLINE | ID: mdl-23295318
7.
Performance Characteristics of the BluePrint® Breast Cancer Diagnostic Test.
Transl Oncol
; 13(4): 100756, 2020 Apr.
Article
in English
| MEDLINE | ID: mdl-32208353
8.
Controlling technical variation amongst 6693 patient microarrays of the randomized MINDACT trial.
Commun Biol
; 3(1): 397, 2020 07 27.
Article
in English
| MEDLINE | ID: mdl-32719399
9.
A role for PtdIns(4,5)P2 and PIP5Kalpha in regulating stress-induced apoptosis.
Curr Biol
; 16(18): 1850-6, 2006 Sep 19.
Article
in English
| MEDLINE | ID: mdl-16979564
10.
Assaying endogenous phosphatidylinositol-4-phosphate 5-kinase (PIP5K) activities.
Methods Mol Biol
; 462: 391-402, 2009.
Article
in English
| MEDLINE | ID: mdl-19160683
11.
Decentralization of Next-Generation RNA Sequencing-Based MammaPrint® and BluePrint® Kit at University Hospitals Leuven and Curie Institute Paris.
Transl Oncol
; 12(12): 1557-1565, 2019 Dec.
Article
in English
| MEDLINE | ID: mdl-31513983
12.
MammaPrint and BluePrint Molecular Diagnostics Using Targeted RNA Next-Generation Sequencing Technology.
J Mol Diagn
; 21(5): 808-823, 2019 09.
Article
in English
| MEDLINE | ID: mdl-31173928
13.
Microarray analysis of bleomycin-exposed lymphoblastoid cells for identifying cancer susceptibility genes.
Mol Cancer Res
; 4(2): 71-7, 2006 Feb.
Article
in English
| MEDLINE | ID: mdl-16513838
14.
A Computational Workflow Translates a 58-Gene Signature to a Formalin-Fixed, Paraffin-Embedded Sample-Based Companion Diagnostic for Personalized Treatment of the BRAF-Mutation-Like Subtype of Colorectal Cancers.
High Throughput
; 6(4)2017 Nov 06.
Article
in English
| MEDLINE | ID: mdl-29479053
15.
Prognostic Value of MammaPrint® in Invasive Lobular Breast Cancer.
Biomark Insights
; 11: 139-146, 2016.
Article
in English
| MEDLINE | ID: mdl-27980389
16.
Integration of genomic, transcriptomic and proteomic data identifies two biologically distinct subtypes of invasive lobular breast cancer.
Sci Rep
; 6: 18517, 2016 Jan 05.
Article
in English
| MEDLINE | ID: mdl-26729235
17.
Involvement of cell cycle control in bleomycin-induced mutagen sensitivity.
Environ Mol Mutagen
; 40(2): 79-84, 2002.
Article
in English
| MEDLINE | ID: mdl-12203399
18.
MammaPrint molecular diagnostics on formalin-fixed, paraffin-embedded tissue.
J Mol Diagn
; 16(2): 190-7, 2014 Mar.
Article
in English
| MEDLINE | ID: mdl-24378251
Results
1 -
18
de 18
1
Next >
>>